Unknown

Dataset Information

0

Ex Vivo PD-L1/PD-1 Pathway Blockade Reverses Dysfunction of Circulating CEA-Specific T Cells in Pancreatic Cancer Patients.


ABSTRACT: Purpose: Carcinoembryonic antigen (CEA) is a candidate target for cellular immunotherapy of pancreatic cancer. In this study, we have characterized the antigen-specific function of autologous cytotoxic T lymphocytes (CTL) specific for the HLA-A2-restricted peptide, pCEA691-699, isolated from the peripheral T-cell repertoire of pancreatic cancer patients and sought to determine if ex vivo PD-L1 and TIM-3 blockade could enhance CTL function.Experimental Design: CD8+ T-cell lines were generated from peripheral blood mononuclear cells of 18 HLA-A2+ patients with pancreatic cancer and from 15 healthy controls. In vitro peptide-specific responses were evaluated by flow cytometry after staining for intracellular cytokine production and carboxy fluorescein succinimydyl ester cytotoxicity assays using pancreatic cancer cell lines as targets.Results: Cytokine-secreting functional CEA691-specific CTL lines were successfully generated from 10 of 18 pancreatic cancer patients, with two CTL lines able to recognize and kill both CEA691 peptide-loaded T2 cells and CEA+ HLA-A2+ pancreatic cancer cell lines. In the presence of ex vivo PD-L1 blockade, functional CEA691-specific CD8+ T-cell responses, including IFN? secretion and proliferation, were enhanced, and this effect was more pronounced on Ag-specific T cells isolated from tumor draining lymph nodes.Conclusions: These data demonstrate that CEA691-specific CTL can be readily expanded from the self-restricted T-cell repertoire of pancreatic cancer patients and that their function can be enhanced by PD-L1 blockade. Clin Cancer Res; 23(20); 6178-89. ©2017 AACR.

SUBMITTER: Chen Y 

PROVIDER: S-EPMC5683391 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

<i>Ex Vivo</i> PD-L1/PD-1 Pathway Blockade Reverses Dysfunction of Circulating CEA-Specific T Cells in Pancreatic Cancer Patients.

Chen Yuan Y   Xue Shao-An SA   Behboudi Shahriar S   Mohammad Goran H GH   Pereira Stephen P SP   Morris Emma C EC  

Clinical cancer research : an official journal of the American Association for Cancer Research 20170714 20


<b>Purpose:</b> Carcinoembryonic antigen (CEA) is a candidate target for cellular immunotherapy of pancreatic cancer. In this study, we have characterized the antigen-specific function of autologous cytotoxic T lymphocytes (CTL) specific for the HLA-A2-restricted peptide, pCEA691-699, isolated from the peripheral T-cell repertoire of pancreatic cancer patients and sought to determine if <i>ex vivo</i> PD-L1 and TIM-3 blockade could enhance CTL function.<b>Experimental Design:</b> CD8<sup>+</sup>  ...[more]

Similar Datasets

| S-EPMC9335501 | biostudies-literature
| S-EPMC7889918 | biostudies-literature
| S-EPMC5286375 | biostudies-literature
| S-EPMC5809290 | biostudies-literature
| S-EPMC4258151 | biostudies-other
| S-EPMC10493609 | biostudies-literature
| S-EPMC8414725 | biostudies-literature
| S-EPMC8649012 | biostudies-literature
| S-EPMC7460585 | biostudies-literature
| S-EPMC6209395 | biostudies-literature